TD Waterhouse Canada’s ProMIS Neurosciences PMN Stock Holding History

TD Waterhouse Canada’s Portfolio PMN Stock Details PMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$65	Sell	5 -20	-80%	-$298	﹤0.01%	2246
2025 Q4	$170	Sell	25 -13	-34%	-$127	﹤0.01%	1947
2025 Q3	$422	Buy	38 +33	+660%	+$457	﹤0.01%	1942
2025 Q2	$64	Hold	5	–	–	﹤0.01%	1925
2025 Q1	$94	Hold	5	–	–	﹤0.01%	1868
2024 Q4	$126	Hold	5	–	–	﹤0.01%	1876
2024 Q3	$163	Hold	5	–	–	﹤0.01%	1799
2024 Q2	$202	Buy	+5	New	+$234	﹤0.01%	1813
2024 Q1	–	Sell	-6	Closed	-$281	–	1903
2023 Q4	$281	Hold	6	–	–	﹤0.01%	1622
2023 Q3	$391	Hold	6	–	–	﹤0.01%	1613
2023 Q2	$745	Hold	6	–	–	﹤0.01%	1627
2023 Q1	$946	Hold	6	–	–	﹤0.01%	1604
2022 Q4	$900	Hold	6	–	–	﹤0.01%	1569
2022 Q3	$1.21K	Buy	+6	New	+$884	﹤0.01%	1560

Other funds holding PMN

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TECP

Trails Edge Capital Partners Atlanta, Georgia $437M AUM

ABG

Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Yu Fan $97M AUM 57.2% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $273M AUM

TD Waterhouse Canada's PMN Position: Q1 2026 in Review

TD Waterhouse Canada reduced its ProMIS Neurosciences (PMN) stake by 80% in Q1 2026, selling an estimated $298 and leaving 5 shares worth $65. The position accounts for ﹤0.01% of the portfolio, ranked #2246.

TD Waterhouse Canada first reported a position in PMN in Q3 2022 and has held it in 14 quarters since. The position peaked at $1.21K in Q3 2022. 25 funds tracked by Wall St. Rank hold PMN as of Q1 2026.

TD Waterhouse Canada held 5 shares of ProMIS Neurosciences worth $65 as of Q1 2026.
TD Waterhouse Canada sold 20 ProMIS Neurosciences shares in Q1 2026, an estimated $298.
ProMIS Neurosciences made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q1 2026, its #2246 holding.
TD Waterhouse Canada first reported a position in ProMIS Neurosciences in Q3 2022 and has held it in 14 quarters since.
TD Waterhouse Canada's ProMIS Neurosciences position peaked at $1.21K in Q3 2022.
25 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q1 2026.

Based on TD Waterhouse Canada's 13F filing for Q1 2026, filed 12 May 2026.